| 2026-02-18 |
详情>>
股本变动：
变动后总股本4331.78万股
|
| 2026-02-18 |
详情>>
业绩披露：
2025年年报每股收益-0.1美元,归母净利润-436.6万美元,同比去年增长-105.71%
|
| 2026-02-17 |
财报披露：
美东时间 2026-02-17 盘后发布财报
|
| 2025-11-05 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.46美元,归母净利润-1977.7万美元,同比去年增长-131.04%
|
| 2025-08-06 |
详情>>
业绩披露：
2025年中报每股收益-0.43美元,归母净利润-1872.4万美元,同比去年增长-144.3%
|
| 2025-05-07 |
详情>>
业绩披露：
2025年一季报每股收益-0.28美元,归母净利润-1192.3万美元,同比去年增长-163.43%
|
| 2025-04-09 |
股东大会：
将于2025-05-20召开股东大会
会议内容 ▼▲
- 1.To elect the seven directors named in the proxy statement to the Board of Directors of Genco;
2.To approve a non-binding, advisory resolution regarding the compensation of Genco’s named executive officers;
3.To ratify the appointment of Deloitte & Touche LLP as the independent auditors of Genco for the fiscal year ending December 31, 2025;
4.To transact such other business as may properly come before the Annual Meeting or at any adjournment or postponement thereof.
|
| 2025-02-21 |
详情>>
业绩披露：
2022年年报每股收益3.74美元,归母净利润1.59亿美元,同比去年增长-12.87%
|
| 2025-02-21 |
详情>>
业绩披露：
2024年年报每股收益1.77美元,归母净利润7640.10万美元,同比去年增长693.64%
|
| 2024-11-06 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.42美元,归母净利润-1780.8万美元,同比去年增长-113.71%
|
| 2024-11-06 |
详情>>
业绩披露：
2024年三季报(累计)每股收益1.48美元,归母净利润6372.40万美元,同比去年增长457.84%
|
| 2024-08-07 |
详情>>
业绩披露：
2024年中报每股收益0.98美元,归母净利润4226.50万美元,同比去年增长197.72%
|
| 2024-05-08 |
详情>>
业绩披露：
2024年一季报每股收益0.44美元,归母净利润1879.80万美元,同比去年增长613.67%
|
| 2024-04-16 |
股东大会：
将于2024-05-23召开股东大会
会议内容 ▼▲
- 1.To elect seven directors named in the proxy statement to the Board of Directors of Genco;
2.To approve a non-binding, advisory resolution regarding the compensation of Genco’s named executive officers;
3.To ratify the appointment of Deloitte & Touche LLP as the independent auditors of Genco for the fiscal year ending December 31, 2024.
|
| 2024-02-27 |
详情>>
业绩披露：
2023年年报每股收益-0.3美元,归母净利润-1287万美元,同比去年增长-108.12%
|
| 2023-04-06 |
股东大会：
将于2023-05-16召开股东大会
会议内容 ▼▲
- 1.To elect the six directors named in the proxy statement to the Board of Directors of Genco;
2.To approve a non-binding, advisory resolution regarding the compensation of Genco’s named executive officers;
3.To ratify the appointment of Deloitte & Touche LLP as the independent auditors of Genco for the fiscal year ending December 31, 2023;
4.To transact such other business as may properly come before the Annual Meeting or at any adjournment or postponement thereof.
|
| 2022-04-15 |
股东大会：
将于2022-05-16召开股东大会
会议内容 ▼▲
- 1.To elect the seven directors named in the proxy statement to the Board of Directors of Genco;
2.To approve a non-binding, advisory resolution regarding the compensation of Genco’s named executive officers;
3.To ratify the appointment of Deloitte & Touche LLP as the independent auditors of Genco for the fiscal year ending December 31, 2022;
4.To transact such other business as may properly come before the Annual Meeting or at any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-02 |
股东大会：
将于2021-05-13召开股东大会
会议内容 ▼▲
- 1.To elect the seven directors named in the proxy statement to the Board of Directors of Genco;
2.To approve a non-binding, advisory resolution regarding the compensation of Genco’s named executive officers;
3.To consider and act upon a non-binding, advisory proposal on the frequency of the advisory vote on the compensation of Genco’s named executive officers;
4.To approve an amendment to Genco’s 2015 Equity Incentive Plan to increase the number of shares of common stock available for awards under the plan by 2,000,000 shares;
5.To ratify the appointment of Deloitte & Touche LLP as the independent auditors of Genco for the fiscal year ending December 31, 2021;
6.To consider and vote upon a proposal to amend Genco’s Second Amended and Restated Articles of Incorporation to add a federal forum selection provision (the “Federal Forum Amendment”);
7.To transact such other business as may properly come before the Annual Meeting or at any adjournment or postponement thereof.
|
| 2020-06-25 |
股东大会：
将于2020-07-15召开股东大会
会议内容 ▼▲
- 1.To elect the eight directors named in the proxy statement to the Board of Directors of Genco;
2.To ratify the appointment of Deloitte & Touche LLP as the independent auditors of Genco for the fiscal year ending December 31, 2020;
3.To consider and vote upon a proposal to amend the Company’s Second Amended and Restated Articles of Incorporation to allow the Board of Directors of the Company to set the size of the Board of Directors (the “Board Size Amendment”);
4.To transact such other business as may properly come before the Annual Meeting or at any adjournment or postponement thereof.
|
| 2020-05-12 |
股东大会：
将于2020-05-13召开股东大会
会议内容 ▼▲
- 1.To elect the eight directors named in the proxy statement to the Board of Directors of Genco;
2.To ratify the appointment of Deloitte & Touche LLP as the independent auditors of Genco for the fiscal year ending December 31, 2020;
3.To consider and vote upon a proposal to amend the Company’s Second Amended and Restated Articles of Incorporation to allow the Board of Directors of the Company to set the size of the Board of Directors (the “Board Size Amendment”);
4.To transact such other business as may properly come before the Annual Meeting or at any adjournment or postponement thereof.
|
| 2019-04-05 |
股东大会：
将于2019-05-15召开股东大会
会议内容 ▼▲
- 1.To elect the nine directors named in the proxy statement to the Board of Directors of Genco;_x000D_
2.To ratify the appointment of Deloitte & Touche LLP as the independent auditors of Genco for the fiscal year ending December 31, 2019;_x000D_
3.To transact such other business as may properly come before the Annual Meeting or at any adjournment or postponement thereof.
|
| 2018-04-23 |
股东大会：
将于2018-05-15召开股东大会
会议内容 ▼▲
- 1.To elect the nine directors named in the proxy statement to the Board of Directors of Genco;
2.To approve a non-binding, advisory resolution regarding the compensation of our named executive officers;
3.To ratify the appointment of Deloitte & Touche LLP as the independent auditors of Genco for the fiscal year ending December 31, 2018;
4.To transact such other business as may properly come before the Annual Meeting or at any adjournment or postponement thereof.
|
| 2017-04-24 |
股东大会：
将于2017-05-17召开股东大会
会议内容 ▼▲
- 1.To elect the nine directors named in the proxy statement to the Board of Directors of Genco;
2.To approve an amendment to the Company’s 2015 Equity Incentive Plan to increase the number of shares of common stock available for awards under the plan to 2,750,000 shares;
3.To ratify the appointment of Deloitte & Touche LLP as the independent auditors of Genco for the fiscal year ending December 31, 2017;
4.To transact such other business as may properly come before the Annual Meeting or at any adjournment or postponement thereof.
|
| 2016-12-05 |
股东大会：
将于2017-01-04召开股东大会
会议内容 ▼▲
- 1.To approve, in accordance with Section 312.03 of the NYSE Listed Company Manual, the issuance and sale of up to 27,061,856 shares of common stock of the Company (subject to adjustment) upon the conversion of shares of convertible preferred stock of the Company purchased by certain investors in a private placement, as more fully described in the accompanying proxy statement;
2.To consider and vote upon a proposal to amend the Company’s second amended and restated articles of incorporation to increase the size of the Board of Directors of the Company from eight (8) directors to nine (9) directors (the “Board Increase Amendment”);
3.To consider and vote upon any proposal to approve adjournments or postponements of the Special Meeting, if necessary or appropriate, to permit further solicitation of proxies if there are not sufficient votes at the time of the Special Meeting to approve and adopt Proposals Nos. 1 and 2;
4.To transact such other business as may properly come before the Special Meeting or at any adjournment or postponement thereof.
|
| 2016-04-27 |
股东大会：
将于2016-05-18召开股东大会
会议内容 ▼▲
- 1.To elect the eight directors named in the proxy statement to the Board of Directors of Genco;
2.To ratify the appointment of Deloitte & Touche LLP as the independent auditors of Genco for the fiscal year ending December 31, 2016;
3.To transact such other business as may properly come before the Annual Meeting or at any adjournment or postponement thereof.
|
| 2016-03-25 |
股东大会：
将于2016-04-15召开股东大会
会议内容 ▼▲
- 1.To approve a proposal to amend the second amended and restated articles of incorporation of the Company to increase the number of authorized shares of our common stock from 250,000,000 to 500,000,000;
2.To approve a proposal to amend the second amended and restated articles of incorporation of the Company to authorize the issuance of up to 100,000,000 shares of preferred stock, in one or more classes or series as determined by the Board;
3.To grant discretionary authority to the Board of Genco to amend the second amended and restated articles of incorporation of the Company to effect a reverse stock split of the Company’s issued and outstanding shares of common stock at a ratio at a ratio between 1-for-2 and 1-for-25, with such ratio to be determined by the sole discretion of the Board (the “Reverse Stock Split”) and with such Reverse Stock Split to be effective at such time and date, if at all, as determined by the Board, but no later than one year after shareholder approval thereof;
4.To consider and vote upon any proposal to approve adjournments or postponements of the Special Meeting, if necessary or appropriate, to permit further solicitation of proxies if there are not sufficient votes at the time of the Special Meeting to approve and adopt Proposal Nos. 1 through 3;
5.To transact such other business as may properly come before the Special Meeting or at any adjournment or postponement thereof.
|
| 2015-06-15 |
股东大会：
将于2015-07-17召开股东大会
会议内容 ▼▲
- 1.To consider and vote upon a proposal to approve and adopt the Agreement and Plan of Merger, dated as of April 7, 2015, as amended (the "merger agreement"), by and among Baltic Trading Limited ("Baltic Trading"), Poseidon Merger Sub Limited ("merger sub"), and Genco, pursuant to which each share of Baltic Trading common stock (other than shares held by Genco, Baltic Trading, or any of their respective wholly owned subsidiaries) shall be automatically converted into the right to receive 0.216 shares of common stock of Genco, and to approve the merger of merger sub with and into Baltic Trading, with Baltic Trading continuing as the surviving corporation and an indirect wholly owned subsidiary of Genco, which will continue to be a publicly traded company (the "merger");
2.To consider and vote upon a proposal to amend Genco's second amended and restated articles of incorporation to increase the size of the Board of Directors of Genco from seven (7) directors to eight (8) directors by increasing the number of Class I Directors from three (3) directors to four (4) directors (the "Board Increase Amendment");
3.To elect Peter C. Georgiopoulos, Ian Ashby and Eugene I. Davis as Class I Directors to the Board of Directors of Genco (the "Genco directors proposal");
4.To ratify the appointment of Deloitte & Touche LLP as the independent auditors of Genco for the fiscal year ending December 31, 2015 (the "Genco accountant proposal");
5.To approve a non-binding, advisory resolution regarding the compensation of Genco's named executive officers (the "Genco compensation proposal");
6.To consider and act upon a non-binding, advisory proposal on the frequency of the advisory vote on the compensation of Genco's named executive officers (the "Genco advisory vote proposal");
7.To consider and vote upon any proposal to approve adjournments or postponements of the Genco Annual Meeting, if necessary, to permit further solicitation of proxies if there are not sufficient votes at the time of the Genco Annual Meeting to approve and adopt the merger agreement and approve the merger;
8.To transact such other business as may properly come before the Genco Annual Meeting or at any adjournment or postponement thereof.
|